TickerFactsScreenerDevelopers

Aura Biosciences, Inc. (AURA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$24.32M2021: -$32.41M2022: -$54.60M2023: -$63.85M2024: -$79.81M2025: -$84.74M-$84.74M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$84.74M-6.2%
2024-$79.81M-25.0%
2023-$63.85M-16.9%
2022-$54.60M-68.5%
2021-$32.41M-33.3%
2020-$24.32M—